This page shows results related to Alaway and Ocular Discomfort from the FDA Adverse Event Reporting System (AERS). The adverse event Ocular Discomfort has been reported to the FDA a total of 7 times for Alaway.
Learn More About Alaway Adverse EventsThe Proportional Reporting Ratio (PRR) for Alaway and Ocular Discomfort is 203. The chart below compares this proportional reporting ratio of Ocular Discomfort for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Ocular Discomfort.
| Ocular Discomfort | |
| Alaway | 50 |
NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.
Of those reporting Ocular Discomfort, why were they taking Alaway?
| Eye Pruritus | 3 |
| Drug Use For Unknown Indication | 1 |
Which medications reported to the FDA are most commonly associated with Ocular Discomfort?
| Xalatan | 28 |
| Exjade | 19 |
| Restasis | 17 |
| Lucentis | 14 |
| Sandostatin Lar | 11 |
| Forteo | 11 |
| Valsartan And Hydrochlorothiazide | 10 |
| Latisse | 9 |
| Lyrica | 9 |
| Remicade | 8 |
| Cialis | 8 |
 Show More |
